The example embodiments relate to well treatment compositions and methods utilizing nano-particles and, more particularly, to well cement compositions and methods utilizing particulate nano-silica.
In general, well treatments include a wide variety of methods that may be performed in oil, gas, geothermal and/or water wells, such as drilling, completion and workover methods. The drilling, completion and workover methods may include, but are not limited to, drilling, cementing, logging, perforating, fracturing, acidizing, gravel packing, and conformance methods. Many of these well treatments are designed to enhance and/or facilitate the recovery of desirable fluids from a subterranean well.
In cementing methods, such as well construction and remedial cementing, well cement compositions are commonly utilized. For example, in subterranean well construction, a pipe string (e.g., casing and liners) may be run into a well bore and cemented in place using a cement composition. The process of cementing the pipe string in place is commonly referred to as “primary cementing.” In a typical primary cementing method, a cement composition may be pumped into an annulus between the walls of the well bore and the exterior surface of the pipe string disposed therein. The cement composition sets in the annular space, thereby forming an annular sheath of hardened, substantially impermeable cement that supports and positions the pipe string in the well bore and bonds the exterior surface of the pipe string to the subterranean formation. Among other things, the annular sheath of set cement surrounding the pipe string functions to prevent the migration of fluids in the annulus, as well as protecting the pipe string from corrosion. Cement compositions also may be used in remedial cementing methods, such as squeeze cementing and the placement of cement plugs.
In operation, the annular sheath of cement formed between the well bore and the pipe string often suffers structural failure due to pipe movements which cause shear stresses to be exerted on the set cement. Such stress conditions are commonly the result of relatively high fluid pressures and/or temperatures inside the cemented pipe string during testing, perforating, fluid injection or fluid production. For example, such stress may occur in wells subjected to steam recovery or production of hot formation fluids from high-temperature formations. The high-internal pipe pressure and/or temperature can result in the expansion of the pipe string, both radially and longitudinally, which places stresses on the cement sheath causing the cement bond between the exterior surfaces of the pipe or the well bore walls, or both, to fail and thus allow leakage of formation fluids and so forth. Accordingly, it may be desirable for the cement composition utilized for cementing pipe strings in the well bores to develop high strength after setting and to have sufficient resiliency (e.g., elasticity and ductility) to resist loss of the cement bond between the exterior surfaces of the pipe or the well bore walls, or both. Also, it may be desirable for the cement composition to be able to resist cracking and/or shattering that may result from other forces on the cement sheath. For example, it may be desirable for the cement sheath to include structural characteristics that protect its structural integrity from forces associated with formation shifting, overburden pressure, subsidence, tectonic creep, pipe movements, impacts and shocks subsequently generated by drilling and other well operations. In addition to including components that improve mechanical properties of the cement, in a number of cementing methods, it may also be desirable to include one or more set accelerators in the well cement compositions to counteract certain constituents and/or environmental characteristics that excessively slow set times. For example, among other things, low temperatures and cement additives (e.g., fluid loss control additives and dispersants) can cause or contribute to an excessive set time for a cement composition. Accordingly, in certain situations, it may be desirable to reduce the set time by including a set accelerator in the cement composition. That is, the set accelerator may be included in a cement composition to counteract components of the cement composition or conditions surrounding the cement composition that are causing an excessive set time.
These drawings illustrate certain aspects of some of the embodiments of the present method, and should not be used to limit or define the method.
The FIGURE depicts an example of a system for delivering treatment fluids.
The example embodiments relate to well treatment compositions and methods utilizing nano-particles and, more particularly, to well cement compositions and methods utilizing particulate nano-silica.
An exemplary embodiment of the cement compositions comprises cement, water and particulate nano-silica. Those of ordinary skill in the art will appreciate that the exemplary cement compositions generally should have a density suitable for a particular application. By way of example, the cement composition may have a density in the range of from about 4 pounds per gallon (“ppg”) to about 20 ppg. In exemplary embodiments, the cement compositions may have a density in the range of from about 8 ppg to about 17 ppg. Exemplary embodiments of the cement compositions may be foamed or unfoamed or may comprise other means to reduce their densities, such as hollow microspheres, low-density elastic beads, or other density-reducing additives known in the art. Those of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate density for a particular application.
Exemplary embodiments of the cement compositions comprise a cement. Any of a variety of cements suitable for use in subterranean cementing operations may be used in accordance with exemplary embodiments. Suitable examples include hydraulic cements that comprise calcium, aluminum, silicon, oxygen and/or sulfur, which set and harden by reaction with water. Such hydraulic cements, include, but are not limited to, Portland cements, pozzolana cements, gypsum cements, high-alumina-content cements, slag cements, silica cements and combinations thereof. In certain embodiments, the hydraulic cement may comprise a Portland cement. The Portland cements that may be suited for use in exemplary embodiments are classified as Class A, C, H and G cements according to American Petroleum Institute, API Specification for Materials and Testing for Well Cements, API Specification 10, Fifth Ed., Jul. 1, 1990.
The water used in exemplary embodiments of the cement compositions may be freshwater or saltwater (e.g., water containing one or more salts dissolved therein, seawater, brines, saturated saltwater, etc.). In general, the water may be present in an amount sufficient to form a pumpable slurry. In exemplary embodiments, the water may be present in the cement compositions in an amount in the range of from about 33% to about 200% by weight of the cement on a dry basis (“bwoc”). In exemplary embodiments, the water may be present in an amount in the range of from about 35% to about 70% bwoc.
In addition, exemplary embodiments of the cement compositions comprise nano-silica. The nano-silica may be described as particulate nano-silica. That is, the nano-silica may be particulate in nature and not, for example, a colloidal silica or a suspension of silica in solution. Indeed, in one embodiment, the particulate nano-silica may be added to the cement composition as a dry nano-silica powder. Generally, the particulate nano-silica may be defined as nano-silica having a particle size of less than or equal to about 100 nm. For example, the particulate nano-silica may have a particle size in the range of from about 1 nm to about 100 nm (about 1×109 m to about 100×10−9 m). In certain exemplary embodiments, the particulate nano-silica may have a particle size of less than or equal to about 50 nm. For example, the particulate nano-silica may have a particle size in the range of from about 5 nm to about 50 nm. In further exemplary embodiments, the particulate nano-silica may have a particle size of less than or equal to about 30 nm. For example, the particulate nano-silica may have a particle size in the range of from about 5 nm to about 30 nm. However, it should be noted that the particulate nano-silica may be utilized in combination with differently sized silica particles in accordance with present embodiments. For example, a number of silica particles with particle sizes greater than 100 nm may be included in a cement composition in accordance with present embodiments.
It is now recognized that the particulate nano-silica utilized with present embodiments, which may include silicon dioxide, may have an impact on certain physical characteristics of resulting cements. For example, relative to inclusion of colloidal silica or larger silica particles in a cement slurry, inclusion of particulate nano-silica in the cement slurry may provide improved mechanical properties, such as compressive strength, tensile strength, Young's modulus and Poisson's ratio. In addition, the particulate nano-silica also may be included in the cement composition as a set accelerator to accelerate the set time of the resultant cement composition. Accordingly, a cement composition in accordance with present embodiments may comprise a sufficient amount of particulate nano-silica to provide the desired characteristics in a resulting cement. In exemplary embodiments, the particulate nano-silica may be present in the cement composition in an amount in the range of from about 1% to about 25% bwoc. In exemplary embodiments, the particulate nano-silica may be present in the cement composition in an amount in the range of from about 5% to about 15% bwoc.
Other additives suitable for use in subterranean cementing operations also may be added to exemplary embodiments of the cement compositions. Examples of such additives include, strength-retrogression additives, set accelerators, weighting agents, weight-reducing additives, heavyweight additives, lost-circulation materials, filtration-control additives, dispersants, defoaming agents, foaming agents, and combinations thereof. Specific examples of these, and other, additives include crystalline silica, amorphous silica, salts, fibers, hydratable clays, vitrified shale, microspheres, fly ash, lime, latex, thixotropic additives, combinations thereof and the like. A person having ordinary skill in the art, with the benefit of this disclosure, will readily be able to determine the type and amount of additive useful for a particular application and desired result.
As will be appreciated by those of ordinary skill in the art, exemplary embodiments of the cement compositions may be used in a variety of subterranean applications, including primary and remedial cementing. Exemplary embodiments of the cement compositions may be introduced into a subterranean formation and allowed to set therein. Exemplary embodiments of the cement compositions may comprise cement, water and the particulate nano-silica. By way of example, in exemplary primary cementing embodiments, a cement composition may be introduced into a space between a subterranean formation and a pipe string located in the subterranean formation. The cement composition may be allowed to set to form a hardened mass in the space between the subterranean formation and the pipe string. In addition, in exemplary remedial cementing embodiments, a cement composition may be used, for example, in squeeze-cementing operations or in the placement of cement plugs. One or more hydrocarbons (e.g., oil, gas, etc.) may be produced from a well bore penetrating the subterranean formation.
While the preceding discussion is directed to the use of particulate nano-silica, those of ordinary skill in the art will also appreciate that it may be desirable to utilize other types of nano-particles, in accordance with embodiments. Examples of such nano-particles include nano-alumina, nano-zinc oxide, nano-boron, nano-iron oxide and combinations thereof. In certain exemplary embodiments, the nano-particles may be particulate in nature and not, for example, a colloidal nano-particle or a suspension of the nano-particle in solution. Furthermore, while the preceding discussion is directed to the use of particulate nano-silica in well cementing methods, those of ordinary skill in the art will appreciate that the present technique also encompasses the use of nano-particles in any of a variety of different subterranean treatments. For example, the nano-particles may be included in any of a number of well treatment fluids that may be used in subterranean treatments, including drilling fluids, completion fluids, stimulation fluids and well clean-up fluids. In accordance with another embodiment, the nano-particles may be included as proppant in a well treatment fluid. For example, a well treatment fluid containing the nano-particles may be introduced into a subterranean formation at or above a pressure sufficient to create or enhance or more fractures in the subterranean formation. Enhancing a fracture includes enlarging a pre-existing fracture in the formation. At least a portion of the nano-particles may be deposited in the one or more fractures such that the fractures are prevented from fully closing upon the release of pressure, forming conductive channels through which fluids may flow to (or from) the well bore.
With regard to fracturing fluids, these fluids are commonly viscosified, gelled and/or crosslinked. The function of the fracturing fluid is used to apply pressure to the formation rocks around the well, up to a pressure whereby the formation is fractured. One essential function of these fluids is to be capable of suspending a proppant and especially to carry this proppant without settling into the fracture created by the fluid. Once again the rheology, especially the so called “suspension” property, and the stability of these fluids is of first importance, as well as the property of fluid loss control.
In addition to the use of the nano-particles without encapsulation, embodiments may include encapsulation of the nano-particles to facilitate transportation and incorporation of the nano-particles in well treatment fluids (e.g., cement compositions). Specifically, encapsulation of the nano-particles in accordance with present embodiments may include enclosing the nano-particles within an outer coating or container in particulate form. Exemplary methods of encapsulation are set forth in U.S. Pat. Nos. 5,373,901; 6,444,316; 6,527,051; 6,554,071; 7,156,174; and 7,204,312, the relevant disclosures of which are incorporated herein by reference.
Various types of encapsulation may be employed such that the nano-particles (e.g., the particulate nano-silica) are contained but retains its particulate nature and, thus, retains its corresponding impact on physical properties of cement slurries. For example, the nano-particles may be encapsulated within a bag, capsule, layer, coating or the like. Further, the material utilized to encapsulate the nano-particles may be selected to facilitate transportation and/or incorporation of the nano-particles into a well treatment fluid. For example, to facilitate handling of the nano-particles and/or to facilitate timed release of the nano-particles, the encapsulation material may be degradable. This may facilitate handling of the nano-particles by allowing inclusion of the encapsulated nano-particles in a well treatment fluid without requiring that the nano-particles first be removed from the encapsulating material. Further, the encapsulating material may be designed to degrade at a certain rate when in contact with certain materials (e.g., water) so that the nano-particles are released into the well treatment fluid at a desired time. Exemplary water-dissolvable materials that may be utilized to encapsulate the nano-particles are described in U.S. Pat. Nos. 4,961,790 and 5,783,541, the relevant disclosures of which are incorporated herein by reference.
In accordance with exemplary embodiments, the cement compositions may utilize a packing volume fraction suitable for a particular application as desired. As used herein, the term “packing volume fraction” refers to the volume of the particulate materials in a fluid divided by the total volume of the fluid. The size ranges of the preferred particulate materials are selected, as well as their respective proportions, in order to provide a maximized packing volume fraction so that the fluid is in a hindered settling state. It is known that, in such a state, the particulate materials behave “collectively” like a porous solid material. The hindered settling state is believed to correspond, in practice, to a much higher solid material concentration in the fluid than that present in the some traditional cement compositions.
The present embodiments may include a combination of at least three features to obtain a maximum packing volume fraction. One is the use of at least three particulate materials wherein at least three particulate materials are in size ranges “disjointed” from one another. In some embodiments, each of the three particulate materials may include a different particle size selected from the following ranges: about 7 nm to about 50 nm, about 0.05 microns to about 0.5 microns, 0.5 microns to about 10 microns, about 10 microns to about 20 microns, about 20 microns to about 200 microns, about 200 microns to about 800 microns, and greater than about 1 millimeter. For example, a first particulate material may include particles sized from about 7 nm to about 50 nm, a second particulate material may include particles sized from about 0.05 microns to about 0.5 microns, and a third particulate material may include particles sized from about 10 microns to about 20 microns. In accordance with present embodiments, the first particulate material includes at least one of nano-silica, nano-alumina, nano-zinc oxide, nano-boron, nano-iron oxide or combinations thereof. Another feature of present embodiments may include a choice of the proportions of the three particulate materials in relation to the mixing, such that the fluid, when mixed, is in a hindered settling state. Another feature may include the choice of the proportions of the three particulate materials between each other, and according to their respective size ranges, such that the maximum packing volume fraction is at least substantially achieved for the sum total of all particulate materials in the fluid system. Packing volume fraction is described in further detail in U.S. Pat. Nos. 5,518,996 and 7,213,646, the relevant portions of which are incorporated herein by reference.
In various embodiments, systems configured for delivering the treatment fluids described herein to a downhole location are described. In various embodiments, the systems can comprise a pump fluidly coupled to a tubular, the tubular containing a treatment fluid comprising a proppant comprising nano-particulates.
The pump may be a high pressure pump in some embodiments. As used herein, the term “high pressure pump” will refer to a pump that is capable of delivering a fluid downhole at a pressure of about 1000 psi or greater. A high pressure pump may be used when it is desired to introduce the treatment fluid to a subterranean formation at or above a fracture gradient of the subterranean formation, but it may also be used in cases where fracturing is not desired. In some embodiments, the high pressure pump may be capable of fluidly conveying particulate matter, such as proppant particulates, into the subterranean formation. Suitable high pressure pumps will be known to one having ordinary skill in the art and may include, but are not limited to, floating piston pumps and positive displacement pumps.
In other embodiments, the pump may be a low pressure pump. As used herein, the term “low pressure pump” will refer to a pump that operates at a pressure of about 1000 psi or less. In some embodiments, a low pressure pump may be fluidly coupled to a high pressure pump that is fluidly coupled to the tubular. That is, in such embodiments, the low pressure pump may be configured to convey the treatment fluid to the high pressure pump. In such embodiments, the low pressure pump may “step up” the pressure of the treatment fluid before it reaches the high pressure pump.
In some embodiments, the systems described herein can further comprise a mixing tank that is upstream of the pump and in which the treatment fluid is formulated. In various embodiments, the pump (e.g., a low pressure pump, a high pressure pump, or a combination thereof) may convey the treatment fluid from the mixing tank or other source of the treatment fluid to the tubular. In other embodiments, however, the treatment fluid can be formulated offsite and transported to a worksite, in which case the treatment fluid may be introduced to the tubular via the pump directly from its shipping container (e.g., a truck, a railcar, a barge, or the like) or from a transport pipeline. In either case, the treatment fluid may be drawn into the pump, elevated to an appropriate pressure, and then introduced into the tubular for delivery downhole.
The FIGURE shows an illustrative schematic of a system that can deliver treatment fluids of the present invention to a downhole location, according to one or more embodiments. It should be noted that while the FIGURE generally depicts a land-based system, it is to be recognized that like systems may be operated in subsea locations as well. As depicted in the FIGURE, system 1 may include mixing tank 10, in which a treatment fluid of the present invention may be formulated. The treatment fluid may be conveyed via line 12 to wellhead 14, where the treatment fluid enters tubular 16, tubular 16 extending from wellhead 14 into subterranean formation 18. Upon being ejected from tubular 16, the treatment fluid may subsequently penetrate into subterranean formation 18. Pump 20 may be configured to raise the pressure of the treatment fluid to a desired degree before its introduction into tubular 16. It is to be recognized that system 1 is merely exemplary in nature and various additional components may be present that have not necessarily been depicted in the FIGURE in the interest of clarity. Non-limiting additional components that may be present include, but are not limited to, supply hoppers, valves, condensers, adapters, joints, gauges, sensors, compressors, pressure controllers, pressure sensors, flow rate controllers, flow rate sensors, temperature sensors, and the like.
Although not depicted in the FIGURE, the treatment fluid may, in some embodiments, flow back to wellhead 14 and exit subterranean formation 18. In some embodiments, the treatment fluid that has flowed back to wellhead 14 may subsequently be recovered and recirculated to subterranean formation 18.
It is also to be recognized that the disclosed treatment fluids may also directly or indirectly affect the various downhole equipment and tools that may come into contact with the treatment fluids during operation. Such equipment and tools may include, but are not limited to, wellbore casing, wellbore liner, completion string, insert strings, drill string, coiled tubing, slickline, wireline, drill pipe, drill collars, mud motors, downhole motors and/or pumps, surface-mounted motors and/or pumps, centralizers, turbolizers, scratchers, floats (e.g., shoes, collars, valves, etc.), logging tools and related telemetry equipment, actuators (e.g., electromechanical devices, hydromechanical devices, etc.), sliding sleeves, production sleeves, plugs, screens, filters, flow control devices (e.g., inflow control devices, autonomous inflow control devices, outflow control devices, etc.), couplings (e.g., electro-hydraulic wet connect, dry connect, inductive coupler, etc.), control lines (e.g., electrical, fiber optic, hydraulic, etc.), surveillance lines, drill bits and reamers, sensors or distributed sensors, downhole heat exchangers, valves and corresponding actuation devices, tool seals, packers, cement plugs, bridge plugs, and other wellbore isolation devices, or components, and the like. Any of these components may be included in the systems generally described above and depicted in the FIGURE.
To facilitate a better understanding of the present technique, the following examples of some specific embodiments are given. In no way should the following examples be read to limit, or to define, the scope of the invention.
Five different cement slurries (i.e., Slurry A, Slurry B, Slurry C, Slurry D and Slurry E) were prepared. The slurries and resulting set cements were then tested to determine setting or thickening times and other physical properties of each of the five different slurries. As set forth below, the respective test results for the five different slurries demonstrate that inclusion of particulate nano-silica in the slurry reduces the set time and increases the strength of the resulting cement relative to cements resulting from inclusion of the other silica components that were tested.
Slurries A, B, C and D were prepared by dry blending dry components with cement prior to adding water to form the respective slurry. Slurry E was prepared by dry blending dry components with cement prior to adding water and then adding colloidal silica to form the respective slurry. Further, each of the five slurries included a different type of silica. Two of the five slurries included particulate nano-silica in accordance with present embodiments, and the other three included silica in different forms and sizes (e.g., colloidal silica and micro-silica). While the silica included in each of the five slurries was different, the other components utilized in each of the five slurries were similar. Specifically, in addition to a specific type of silica, each of the five slurries included 100% bwoc of Class G cement, 0.5% bwoc of a retarder, and sufficient water to make the density of the slurry approximately 12.00 lbs/gal. The specific retarder utilized in the slurries was HR-5 cement retarder, which is a sulfomethylated lignosulfonate. It should be noted that HR5 cement retarder is available from Halliburton Energy Services, Inc. and is described in U.S. Pat. No. RE31,190.
As set forth above, each of the five slurries included a different type of silica and sufficient water to make the resulting slurry have a density of 12.00 ppg. Slurries A and B included particulate nano-silica in accordance with present embodiments and 15.36 gal/sk of water. Specifically, Slurry A included 15% bwoc of particulate nano-silica having a particle size of approximately 30 nm, and Slurry B included particulate nano-silica having a particle size of approximately 10 nm. Slurry C included 15% bwoc of SILICALITE cement additive and 15.68 gal/sk of water. SILICALITE (compacted) cement additive, which is available from Halliburton Energy Services, Inc., Duncan, Okla., is an amorphous silica generally sized in a range from about 2.5 microns to about 50 microns. Slurry D included 15% bwoc of MICROSAND cement additive and 15.77 gal/sk of water. MICROSAND cement additive, which is available from Halliburton Energy Services, Inc., Duncan, Okla., is a crystalline silica ground to a substantially uniform particle size distribution of approximately 5 to 10 microns. Slurry E included 5.12 gal/sk of GasCon 469™ lightweight cement additive and 10.09 gal/sk of water. GASCON 469 lightweight cement additive is available from Halliburton Energy Services, Inc., Duncan, Okla., and may be defined as a colloidal silicic acid suspension containing suspended silicic acid particles generally having a particle size of less than about 20 nm.
After the five slurries were prepared, tests were performed to determine various physical characteristics associated with inclusion of the different silica components in each of the associated cement compositions. One of these tests was performed to measure a thickening time associated with each of the five slurries. Specifically, the total thickening time (TTT) associated with each cement slurry was determined by performing a thickening-time test in accordance with API Recommended Practice 10, API Specification for Materials and Testing for Well Cements. The measurement of the TTT for each slurry was based on the respective slurry reaching a consistency of 70 Bearden units (Bc) at 80° F. The results of these measurements are set forth for each of the five slurries in Table 1 below.
Additional tests were performed on the cement slurries to determine force-resistance properties (e.g., compressive strength, shear-bond strength, and tensile strength) for each of the slurries. Each of the force-resistance property tests was performed on the respective cement slurries at a temperature of 80° F. and after the slurries had set for 72 hours. The force-resistance property tests included nondestructive and destructive ultrasonic strength tests, a compressive-strength test, a shear-bond test, and a tensile-strength test. The nondestructive and destructive ultrasonic analyzer tests were conducted using a UCA ultrasonic cement analyzer to determine a UCA72 hrs value and a UCAcrush value, respectively. The compressive-strength tests and UCA analyzer tests were performed in accordance with API Recommended Practice 10B. Further, shear-bond and Brazilian-tensile-strength tests were performed to determine shear strength and tensile strength values, respectively, for the different cement compositions. The shear-bond-strength tests were performed as described in SPE 764 entitled “A Study of Cement—Pipe Bonding” by L. G. Carter and G. W. Evans. The Brazilian-tensile-strength tests were performed in accordance with ASTM C496-96. The results of the tests performed on each of the five compositions are shown in Table 1 below.
Samples of Slurries A, C, D and E discussed above were also tested to determine various additional physical properties associated with the resulting set cements and to confirm relative differences demonstrated above. While different instruments and calibration settings were used in the additional testing of the slurries, the test data indicates that relative differences between the different slurries are similar to those differences illustrated in Example 1. Indeed, as indicated above in Example 1, the respective test results in Example 2 for the five different cements demonstrate that inclusion of particulate nano-silica in the cement composition increases the strength of the resulting cement relative to cements resulting from inclusion of the other silica components that were tested.
Three samples for each of the three conventional cement slurries (Slurry C, Slurry D, and Slurry E) and four samples of Slurry A were tested to determine compressive strength, Young's modulus, and Poisson's ratio. The compressive-strength tests were performed in accordance with API Specification 10. It should be noted that the compressive-strength measurements in Example 1 are different than those in Example 2 because different equipment and different calibrations were utilized. However, the relative differences between compressive strengths for each of the five slurries are similar. The Young's modulus and Poisson's ratio were statically determined by means of compression testing using a load frame. The Young's modulus or modulus of elasticity for each sample was obtained by taking a ratio of a simple tension stress applied to each sample to a resulting strain parallel to the tension in that sample. The Poisson's ratio for each sample was determined by calculating a ratio of transverse strain to a corresponding axial strain resulting from uniformly distributed axial stress below a proportional limit of each sample. The values determined for the three samples of each of the five different cement slurries are set forth below in Table 2.
The particular embodiments disclosed above are illustrative only, as the example embodiments may be susceptible to various modifications and alternative forms. However, it should be understood that the embodiments are not intended to be limited to the particular embodiments disclosed. Rather, the embodiments cover all modifications, equivalents and alternatives falling with the scope and spirit of the present invention as defined by the following appended claims. In addition, every range of values (of the form, “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed in the present Description of Specific Embodiments is to be understood as referring to the power set (the set of all subsets) of the respective range of values, and set for the every range encompassed within the broader range of value.
The present application is a continuation-in-part of U.S. patent application Ser. No. 12/833,189, filed on Jul. 9, 2010, which is a divisional of U.S. patent application Ser. No. 12/472,561, filed on May 27, 2009 (now issued as U.S. Pat. No. 7,784,542), which is a continuation-in-part of U.S. patent application Ser. No. 12/426,645, filed on Apr. 20, 2009 (now issued as U.S. Pat. No. 7,806,183), which is a continuation-in-part of U.S. patent application Ser. No. 11/747,002, filed on May 10, 2007 (now issued as U.S. Pat. No. 7,559,369), the entire disclosures of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2094316 | Cross et al. | Sep 1937 | A |
2329940 | Ponzer | Sep 1943 | A |
2729426 | Smith | Jan 1956 | A |
2805719 | Anderson | Sep 1957 | A |
2842205 | Allen et al. | Jul 1958 | A |
2848051 | Willaims | Aug 1958 | A |
2857286 | Striker | Oct 1958 | A |
2871133 | Palonen et al. | Jan 1959 | A |
2880096 | Hurley | Mar 1959 | A |
2890169 | Prokop | Jun 1959 | A |
2933135 | Johnson | Apr 1960 | A |
2945769 | Gama et al. | Jul 1960 | A |
2952318 | Ritch | Sep 1960 | A |
2959223 | Harmon et al. | Nov 1960 | A |
2978024 | Davis | Apr 1961 | A |
3026938 | Huitt et al. | Mar 1962 | A |
3079268 | Brooks | Feb 1963 | A |
3153450 | Foster et al. | Oct 1964 | A |
3168139 | Kennedy et al. | Feb 1965 | A |
3219112 | Sauber et al. | Nov 1965 | A |
3336979 | Ingraham et al. | Aug 1967 | A |
3353601 | Dollarhide et al. | Nov 1967 | A |
3366177 | Powers et al. | Jan 1968 | A |
3381748 | Peters et al. | May 1968 | A |
3454095 | Messenger et al. | Jul 1969 | A |
3467193 | Messenger | Sep 1969 | A |
3499491 | Wyant et al. | Mar 1970 | A |
3557876 | Tragesser | Jan 1971 | A |
3607326 | Serafin | Sep 1971 | A |
RE27271 | Hamsberger et al. | Jan 1972 | E |
3748159 | George | Jul 1973 | A |
3759326 | Christopher et al. | Sep 1973 | A |
3817330 | Christopher et al. | Jun 1974 | A |
3854985 | Suzuki et al. | Dec 1974 | A |
3868999 | Christopher et al. | Mar 1975 | A |
3876005 | Fincher et al. | Apr 1975 | A |
3877522 | Knight et al. | Apr 1975 | A |
3887009 | Miller et al. | Jun 1975 | A |
3887385 | Quist et al. | Jun 1975 | A |
3888311 | Cooke, Jr. | Jun 1975 | A |
3951824 | Maxson et al. | Apr 1976 | A |
3958638 | Johnston | May 1976 | A |
3965986 | Christopher | Jun 1976 | A |
4018617 | Nicholson | Apr 1977 | A |
4031184 | McCord | Jun 1977 | A |
4036301 | Powers et al. | Jul 1977 | A |
4047567 | Childs et al. | Sep 1977 | A |
4142910 | Kraemer et al. | Mar 1979 | A |
4176720 | Wilson | Dec 1979 | A |
4202413 | Messenger | May 1980 | A |
4202795 | Burnham et al. | May 1980 | A |
4235291 | Messenger | Nov 1980 | A |
4268316 | Wills et al. | May 1981 | A |
4274881 | Langton et al. | Jun 1981 | A |
4284433 | Aignesberger et al. | Aug 1981 | A |
4321243 | Comwell et al. | Mar 1982 | A |
4341562 | Ahlbeck | Jul 1982 | A |
4353746 | Birchall et al. | Oct 1982 | A |
RE31190 | Detroit et al. | Mar 1983 | E |
4385935 | Skjeldal | May 1983 | A |
4400474 | Copperthwaite et al. | Aug 1983 | A |
4407677 | Wills et al. | Oct 1983 | A |
4432800 | Kneller et al. | Feb 1984 | A |
4435216 | Diehl et al. | Mar 1984 | A |
4455169 | Chatterji | Jun 1984 | A |
4460292 | Durham et al. | Jul 1984 | A |
4494990 | Harris | Jan 1985 | A |
4506734 | Nolte | Mar 1985 | A |
4515635 | Rao et al. | May 1985 | A |
4519452 | Tsao et al. | May 1985 | A |
4555269 | Rao et al. | Nov 1985 | A |
4614599 | Walker | Sep 1986 | A |
4624711 | Styron | Nov 1986 | A |
4633950 | Delhommer et al. | Jan 1987 | A |
4643362 | Serafin | Feb 1987 | A |
4650520 | Johnsen et al. | Mar 1987 | A |
4660642 | Young | Apr 1987 | A |
4676317 | Fry et al. | Jun 1987 | A |
4676832 | Childs et al. | Jun 1987 | A |
4700777 | Luers | Oct 1987 | A |
4711401 | Serafin | Dec 1987 | A |
4715986 | Gruning et al. | Dec 1987 | A |
4721160 | Parcevaux et al. | Jan 1988 | A |
4732213 | Bennett et al. | Mar 1988 | A |
4741401 | Walles et al. | May 1988 | A |
4741782 | Styron | May 1988 | A |
RE32742 | Skjeldal | Sep 1988 | E |
4770796 | Jacobs | Sep 1988 | A |
4784223 | Worrall et al. | Nov 1988 | A |
4822421 | Crabb | Apr 1989 | A |
4848973 | Yokota et al. | Jul 1989 | A |
4883125 | Wilson et al. | Nov 1989 | A |
4935060 | Dingsoyr | Jun 1990 | A |
4941536 | Brothers et al. | Jul 1990 | A |
4953620 | Bloys et al. | Sep 1990 | A |
4961790 | Smith et al. | Oct 1990 | A |
4992102 | Barbour | Feb 1991 | A |
5030366 | Wilson et al. | Jul 1991 | A |
5049288 | Brothers et al. | Sep 1991 | A |
5058679 | Hale et al. | Oct 1991 | A |
RE33747 | Hartley et al. | Nov 1991 | E |
5086850 | Harris et al. | Feb 1992 | A |
5102558 | McDougall et al. | Apr 1992 | A |
5121795 | Ewert et al. | Jun 1992 | A |
5123487 | Harris et al. | Jun 1992 | A |
5125455 | Harris et al. | Jun 1992 | A |
5127473 | Harris et al. | Jul 1992 | A |
5127955 | Fry | Jul 1992 | A |
5149370 | Claussen et al. | Sep 1992 | A |
5151203 | Riley et al. | Sep 1992 | A |
5183505 | Spinney | Feb 1993 | A |
5203629 | Valle et al. | Apr 1993 | A |
5207832 | Baffreau et al. | May 1993 | A |
5213160 | Nahm et al. | May 1993 | A |
5236501 | Nomachi et al. | Aug 1993 | A |
5238064 | Dahl et al. | Aug 1993 | A |
5253991 | Yokota et al. | Oct 1993 | A |
5263542 | Brothers | Nov 1993 | A |
5266111 | Barbour | Nov 1993 | A |
5292512 | Schaefer et al. | Mar 1994 | A |
5295543 | Terry et al. | Mar 1994 | A |
5305831 | Nahm | Apr 1994 | A |
5314022 | Cowan et al. | May 1994 | A |
5320851 | Mars et al. | Jun 1994 | A |
5327968 | Onan et al. | Jul 1994 | A |
5337824 | Cowan | Aug 1994 | A |
5339903 | Eoff et al. | Aug 1994 | A |
5340397 | Brothers | Aug 1994 | A |
5346012 | Heathman et al. | Sep 1994 | A |
5352288 | Mallow | Oct 1994 | A |
5355954 | Onan | Oct 1994 | A |
5358044 | Hale et al. | Oct 1994 | A |
5358047 | Himes et al. | Oct 1994 | A |
5358049 | Hale et al. | Oct 1994 | A |
5361841 | Hale et al. | Nov 1994 | A |
5361842 | Hale et al. | Nov 1994 | A |
5368103 | Heathman et al. | Nov 1994 | A |
5370185 | Cowan et al. | Dec 1994 | A |
5372641 | Carpenter | Dec 1994 | A |
5373901 | Norman et al. | Dec 1994 | A |
5375661 | Daneshy et al. | Dec 1994 | A |
5382290 | Nahm et al. | Jan 1995 | A |
5383521 | Onan et al. | Jan 1995 | A |
5383967 | Chase | Jan 1995 | A |
5389706 | Heathman et al. | Feb 1995 | A |
5398758 | Onan et al. | Mar 1995 | A |
5398759 | Rodrigues et al. | Mar 1995 | A |
5423379 | Hale et al. | Jun 1995 | A |
5439056 | Cowan | Aug 1995 | A |
5454867 | Brothers et al. | Oct 1995 | A |
5456751 | Zandi et al. | Oct 1995 | A |
5458195 | Totten et al. | Oct 1995 | A |
5464060 | Hale et al. | Nov 1995 | A |
5472051 | Brothers | Dec 1995 | A |
5476142 | Kajita et al. | Dec 1995 | A |
5476144 | Nahm et al. | Dec 1995 | A |
5484480 | Styron | Jan 1996 | A |
5494513 | Fu et al. | Feb 1996 | A |
5499677 | Cowan | Mar 1996 | A |
5509962 | Tang | Apr 1996 | A |
5515921 | Cowan et al. | May 1996 | A |
5518996 | Maroy et al. | May 1996 | A |
5520730 | Barbour | May 1996 | A |
5529624 | Riegler | Jun 1996 | A |
5536311 | Rodrigues | Jul 1996 | A |
5542782 | Carter et al. | Aug 1996 | A |
5551976 | Allen | Sep 1996 | A |
5569324 | Totten et al. | Oct 1996 | A |
5575841 | Dry | Nov 1996 | A |
5580379 | Cowan | Dec 1996 | A |
5585333 | Dahl et al. | Dec 1996 | A |
5588488 | Vijn et al. | Dec 1996 | A |
5588489 | Chatterji et al. | Dec 1996 | A |
5603961 | Suzuki et al. | Feb 1997 | A |
5660624 | Dry | Aug 1997 | A |
5663230 | Haman | Sep 1997 | A |
5673753 | Hale et al. | Oct 1997 | A |
5688844 | Chatterji et al. | Nov 1997 | A |
5693137 | Styron | Dec 1997 | A |
5711383 | Terry et al. | Jan 1998 | A |
5716910 | Totten et al. | Feb 1998 | A |
5728209 | Bury et al. | Mar 1998 | A |
5728654 | Dobson et al. | Mar 1998 | A |
5741357 | Sheikh | Apr 1998 | A |
5766323 | Butler et al. | Jun 1998 | A |
5769939 | Dingsoyr | Jun 1998 | A |
5779787 | Brothers et al. | Jul 1998 | A |
5783541 | Tack et al. | Jul 1998 | A |
5795060 | Stephens | Aug 1998 | A |
5820670 | Chatterji et al. | Oct 1998 | A |
5851960 | Totten et al. | Dec 1998 | A |
5866516 | Costin | Feb 1999 | A |
5874387 | Carpenter et al. | Feb 1999 | A |
5879699 | Lerner | Mar 1999 | A |
5897699 | Chatterji et al. | Apr 1999 | A |
5900053 | Brothers et al. | May 1999 | A |
5913364 | Sweatman | Jun 1999 | A |
5988279 | Udarbe et al. | Nov 1999 | A |
5989334 | Dry | Nov 1999 | A |
6011075 | Parris et al. | Jan 2000 | A |
6022408 | Stokes et al. | Feb 2000 | A |
6027561 | Gruber et al. | Feb 2000 | A |
6060434 | Sweatman et al. | May 2000 | A |
6060535 | Villar et al. | May 2000 | A |
6063738 | Chatterji et al. | May 2000 | A |
6138759 | Chatterji et al. | Oct 2000 | A |
6143069 | Brothers et al. | Nov 2000 | A |
6145591 | Boncan et al. | Nov 2000 | A |
6153562 | Villar et al. | Nov 2000 | A |
6167967 | Sweatman | Jan 2001 | B1 |
6170575 | Reddy et al. | Jan 2001 | B1 |
6210476 | Chatterji | Apr 2001 | B1 |
6227294 | Chatterji | May 2001 | B1 |
6230804 | Mueller et al. | May 2001 | B1 |
6244343 | Brothers et al. | Jun 2001 | B1 |
6245142 | Reddy et al. | Jun 2001 | B1 |
6258757 | Sweatman et al. | Jul 2001 | B1 |
6261360 | Dry | Jul 2001 | B1 |
6277189 | Chugh | Aug 2001 | B1 |
6279655 | Pafitis et al. | Aug 2001 | B1 |
6312515 | Barlet-Gouedard et al. | Nov 2001 | B1 |
6315042 | Griffith et al. | Nov 2001 | B1 |
6332920 | Noik et al. | Dec 2001 | B1 |
6332921 | Brothers et al. | Dec 2001 | B1 |
6367550 | Chatterji et al. | Apr 2002 | B1 |
6379456 | Heathman et al. | Apr 2002 | B1 |
6390197 | Marcoy | May 2002 | B1 |
6402833 | O'Hearn et al. | Jun 2002 | B1 |
6409819 | Ko | Jun 2002 | B1 |
6444316 | Reddy et al. | Sep 2002 | B1 |
6457524 | Roddy | Oct 2002 | B1 |
6471975 | Banovetz et al. | Oct 2002 | B1 |
6478869 | Reddy et al. | Nov 2002 | B2 |
6478870 | Marko | Nov 2002 | B2 |
6488089 | Bour et al. | Dec 2002 | B1 |
6488763 | Brothers et al. | Dec 2002 | B2 |
6488764 | Westerman | Dec 2002 | B2 |
6494951 | Reddy et al. | Dec 2002 | B1 |
6500252 | Chatterji et al. | Dec 2002 | B1 |
6500253 | Norman et al. | Dec 2002 | B2 |
6502636 | Chatterji et al. | Jan 2003 | B2 |
6508305 | Brannon et al. | Jan 2003 | B1 |
6524384 | Griffith et al. | Feb 2003 | B2 |
6527051 | Reddy et al. | Mar 2003 | B1 |
6527849 | Dry | Mar 2003 | B2 |
6547871 | Chatterji et al. | Apr 2003 | B2 |
6547891 | Linden et al. | Apr 2003 | B2 |
6554067 | Davies et al. | Apr 2003 | B1 |
6554071 | Reddy et al. | Apr 2003 | B1 |
6561273 | Brothers et al. | May 2003 | B2 |
6562122 | Dao et al. | May 2003 | B2 |
6565647 | Day et al. | May 2003 | B1 |
6572697 | Gleeson et al. | Jun 2003 | B2 |
6599863 | Palmer et al. | Jul 2003 | B1 |
6610139 | Reddy et al. | Aug 2003 | B2 |
6626243 | Go Boncan | Sep 2003 | B1 |
6631766 | Brothers et al. | Oct 2003 | B2 |
6632527 | McDaniel et al. | Oct 2003 | B1 |
6645288 | Dargaud et al. | Nov 2003 | B1 |
6645290 | Barbour | Nov 2003 | B1 |
6648962 | Berke et al. | Nov 2003 | B2 |
6656265 | Garnier et al. | Dec 2003 | B1 |
6656266 | Barlet-Gouedard et al. | Dec 2003 | B1 |
6660080 | Reddy et al. | Dec 2003 | B2 |
6666268 | Griffith et al. | Dec 2003 | B2 |
6668929 | Griffith et al. | Dec 2003 | B2 |
6689208 | Brothers | Feb 2004 | B1 |
6702044 | Reddy et al. | Mar 2004 | B2 |
6706108 | Polston | Mar 2004 | B2 |
6716282 | Griffith et al. | Apr 2004 | B2 |
6722433 | Brothers et al. | Apr 2004 | B2 |
6729405 | DiLullo et al. | May 2004 | B2 |
6740141 | Espin et al. | May 2004 | B2 |
6767398 | Trato | Jul 2004 | B2 |
6770604 | Reddy | Aug 2004 | B2 |
6776237 | Dao et al. | Aug 2004 | B2 |
6796378 | Reddy et al. | Sep 2004 | B2 |
6797054 | Chatterji et al. | Sep 2004 | B2 |
6808561 | Genge | Oct 2004 | B2 |
6811603 | Brothers et al. | Nov 2004 | B2 |
6823940 | Reddy et al. | Nov 2004 | B2 |
6832651 | Ravi et al. | Dec 2004 | B2 |
6835243 | Brothers et al. | Dec 2004 | B2 |
6837316 | Reddy et al. | Jan 2005 | B2 |
6840318 | Lee et al. | Jan 2005 | B2 |
6840996 | Morioka et al. | Jan 2005 | B2 |
6846357 | Reddy et al. | Jan 2005 | B2 |
6848519 | Reddy et al. | Feb 2005 | B2 |
6861392 | Shaarpour | Mar 2005 | B2 |
6874578 | Garnier et al. | Apr 2005 | B1 |
6881709 | Nelson et al. | Apr 2005 | B2 |
6883609 | Drochon et al. | Apr 2005 | B2 |
6887833 | Brothers et al. | May 2005 | B2 |
6889767 | Reddy et al. | May 2005 | B2 |
6902001 | Dargaud et al. | Jun 2005 | B2 |
6904971 | Brothers et al. | Jun 2005 | B2 |
6907929 | LeRoy-Delage et al. | Jun 2005 | B2 |
6908508 | Brothers | Jun 2005 | B2 |
6908888 | Lee et al. | Jun 2005 | B2 |
6911078 | Barlet-Gouedard et al. | Jun 2005 | B2 |
6926081 | Sweatman et al. | Aug 2005 | B2 |
6962201 | Brothers | Nov 2005 | B2 |
6964302 | Luke et al. | Nov 2005 | B2 |
6978834 | Chatterji | Dec 2005 | B1 |
6982000 | Chatterji | Jan 2006 | B2 |
6983800 | Chatterji | Jan 2006 | B2 |
6989057 | Getzlaf et al. | Jan 2006 | B2 |
7007755 | Reddy et al. | Mar 2006 | B2 |
7013998 | Ray | Mar 2006 | B2 |
7022179 | Dry | Apr 2006 | B1 |
7026272 | Reddy et al. | Apr 2006 | B2 |
7032664 | Lord et al. | Apr 2006 | B2 |
7033975 | Baran et al. | Apr 2006 | B2 |
7036592 | Nguyen | May 2006 | B2 |
7044224 | Nguyen | May 2006 | B2 |
7048053 | Santra et al. | May 2006 | B2 |
7059415 | Bosma et al. | Jun 2006 | B2 |
7073584 | Reddy et al. | Jul 2006 | B2 |
7077203 | Roddy et al. | Jul 2006 | B1 |
7081489 | Chen | Jul 2006 | B2 |
7084092 | Patel et al. | Aug 2006 | B2 |
7084095 | Lee et al. | Aug 2006 | B2 |
7086466 | Roddy | Aug 2006 | B2 |
7087554 | Youngson | Aug 2006 | B2 |
7138446 | Reddy et al. | Nov 2006 | B2 |
7140439 | Luke et al. | Nov 2006 | B2 |
7140440 | Luke et al. | Nov 2006 | B2 |
7143828 | Reddy et al. | Dec 2006 | B2 |
7143832 | Freyer | Dec 2006 | B2 |
7147055 | Brothers et al. | Dec 2006 | B2 |
7147067 | Getzlaf et al. | Dec 2006 | B2 |
7150321 | Luke et al. | Dec 2006 | B2 |
7156173 | Mueller | Jan 2007 | B2 |
7156174 | Roddy et al. | Jan 2007 | B2 |
7160844 | Urbanek | Jan 2007 | B2 |
7172022 | Reddy et al. | Feb 2007 | B2 |
7174962 | Roddy et al. | Feb 2007 | B1 |
7178590 | Vargo | Feb 2007 | B2 |
7182137 | Fyten et al. | Feb 2007 | B2 |
7198104 | Griffith et al. | Apr 2007 | B2 |
7199086 | Roddy et al. | Apr 2007 | B1 |
7204307 | Roddy et al. | Apr 2007 | B2 |
7204310 | Roddy et al. | Apr 2007 | B1 |
7204312 | Roddy et al. | Apr 2007 | B2 |
7213646 | Roddy et al. | May 2007 | B2 |
7217441 | Bour et al. | May 2007 | B2 |
7255739 | Brothers et al. | Aug 2007 | B2 |
7264053 | Vargo, Jr. et al. | Sep 2007 | B2 |
7279447 | Lal et al. | Oct 2007 | B2 |
7284609 | Roddy et al. | Oct 2007 | B2 |
7284611 | Reddy et al. | Oct 2007 | B2 |
7284930 | Shi et al. | Oct 2007 | B2 |
7290613 | Santra et al. | Nov 2007 | B2 |
7294194 | Reddy et al. | Nov 2007 | B2 |
7296597 | Freyer et al. | Nov 2007 | B1 |
7297664 | Santra et al. | Nov 2007 | B2 |
7303014 | Reddy et al. | Dec 2007 | B2 |
7316744 | De La Roij et al. | Jan 2008 | B2 |
7335252 | Roddy et al. | Feb 2008 | B2 |
7337841 | Ravi | Mar 2008 | B2 |
7337842 | Roddy et al. | Mar 2008 | B2 |
7338923 | Roddy et al. | Mar 2008 | B2 |
7341104 | Roddy et al. | Mar 2008 | B2 |
7341106 | Reddy et al. | Mar 2008 | B2 |
7351279 | Brothers | Apr 2008 | B2 |
7353870 | Roddy et al. | Apr 2008 | B2 |
7381263 | Roddy et al. | Jun 2008 | B2 |
7387675 | Roddy et al. | Jun 2008 | B2 |
7393407 | Dingsoyr et al. | Jul 2008 | B2 |
7395860 | Roddy et al. | Jul 2008 | B2 |
7404440 | Reddy et al. | Jul 2008 | B2 |
7409991 | Reddy et al. | Aug 2008 | B2 |
7413014 | Chatterji et al. | Aug 2008 | B2 |
7422060 | Hammami et al. | Sep 2008 | B2 |
7424913 | Roddy | Sep 2008 | B2 |
7431098 | Ohmer et al. | Oct 2008 | B2 |
7435768 | Lecolier et al. | Oct 2008 | B2 |
7445668 | Sommain | Nov 2008 | B2 |
7445669 | Roddy et al. | Nov 2008 | B2 |
7451817 | Reddy et al. | Nov 2008 | B2 |
7459209 | Smith et al. | Dec 2008 | B2 |
7461696 | Nguyen et al. | Dec 2008 | B2 |
7478675 | Roddy et al. | Jan 2009 | B2 |
7482309 | Ravi et al. | Jan 2009 | B2 |
7488705 | Reddy et al. | Feb 2009 | B2 |
7540915 | Lecolier | Jun 2009 | B2 |
7543642 | Reddy et al. | Jun 2009 | B2 |
7544640 | Luke et al. | Jun 2009 | B2 |
7559369 | Roddy et al. | Jul 2009 | B2 |
7572501 | Li et al. | Aug 2009 | B2 |
7576042 | Lewis et al. | Aug 2009 | B2 |
7578347 | Bosma et al. | Aug 2009 | B2 |
7607482 | Roddy | Oct 2009 | B2 |
7631692 | Roddy et al. | Dec 2009 | B2 |
7645817 | Reddy et al. | Jan 2010 | B2 |
7647970 | Mueller et al. | Jan 2010 | B2 |
7650940 | Reddy et al. | Jan 2010 | B2 |
7651563 | Datta et al. | Jan 2010 | B2 |
7658796 | Nordmeyer | Feb 2010 | B2 |
7665537 | Patel et al. | Feb 2010 | B2 |
7674331 | Drochon | Mar 2010 | B2 |
7674332 | Roddy | Mar 2010 | B2 |
7694738 | Reddy et al. | Apr 2010 | B2 |
7717180 | Badalamenti et al. | May 2010 | B2 |
7784542 | Roddy et al. | Aug 2010 | B2 |
7786192 | Birgisson et al. | Aug 2010 | B2 |
7806183 | Roddy et al. | Oct 2010 | B2 |
7837412 | O'Hearn | Nov 2010 | B2 |
7846876 | Koyanagi | Dec 2010 | B2 |
7871702 | Rao | Jan 2011 | B2 |
7892352 | Roddy | Feb 2011 | B2 |
7913757 | Reddy et al. | Mar 2011 | B2 |
7946351 | Freyer | May 2011 | B2 |
8110039 | Hunt | Feb 2012 | B2 |
8114820 | Crews | Feb 2012 | B2 |
8119620 | Schramm | Feb 2012 | B2 |
8183184 | Berkland et al. | May 2012 | B2 |
8183186 | Luo | May 2012 | B2 |
8226879 | Genolet et al. | Jul 2012 | B2 |
8273173 | Mercado et al. | Sep 2012 | B2 |
8333240 | Roddy | Dec 2012 | B2 |
8453746 | Hailey, Jr. et al. | Jun 2013 | B2 |
8455404 | Harrower et al. | Jun 2013 | B2 |
8476203 | Patil et al. | Jul 2013 | B2 |
8499837 | Koons | Aug 2013 | B2 |
8586512 | Roddy et al. | Nov 2013 | B2 |
8598093 | Roddy et al. | Dec 2013 | B2 |
8603952 | Roddy et al. | Dec 2013 | B2 |
8609595 | Morgan et al. | Dec 2013 | B2 |
8685903 | Ravi et al. | Apr 2014 | B2 |
20020117090 | Ku | Aug 2002 | A1 |
20030116887 | Scott | Jun 2003 | A1 |
20040055748 | Reddy et al. | Mar 2004 | A1 |
20040121916 | Kono | Jun 2004 | A1 |
20040147388 | Webber et al. | Jul 2004 | A1 |
20040171499 | Ravi et al. | Sep 2004 | A1 |
20040187740 | Timmons | Sep 2004 | A1 |
20040256102 | Trato | Dec 2004 | A1 |
20050028976 | Nguyen | Feb 2005 | A1 |
20050061206 | Reddy et al. | Mar 2005 | A1 |
20050107265 | Sullivan et al. | May 2005 | A1 |
20050113260 | Wood | May 2005 | A1 |
20050194141 | Sinclair | Sep 2005 | A1 |
20050244641 | Vincent | Nov 2005 | A1 |
20060016598 | Urbanek | Jan 2006 | A1 |
20060075932 | Lecolier et al. | Apr 2006 | A1 |
20060089851 | Silby et al. | Apr 2006 | A1 |
20060151171 | Davies et al. | Jul 2006 | A1 |
20060166834 | Roddy | Jul 2006 | A1 |
20060177661 | Smith | Aug 2006 | A1 |
20060260513 | Guiterrez et al. | Nov 2006 | A1 |
20070012436 | Freyer | Jan 2007 | A1 |
20070056479 | Gray | Mar 2007 | A1 |
20070056732 | Roddy et al. | Mar 2007 | A1 |
20070137528 | LeRoy-Deluge et al. | Jun 2007 | A1 |
20070204765 | LeRoy-Deluge et al. | Sep 2007 | A1 |
20070255457 | Whitcomb et al. | Nov 2007 | A1 |
20070266903 | Gartner et al. | Nov 2007 | A1 |
20080023201 | Huang et al. | Jan 2008 | A1 |
20080108524 | Willberg et al. | May 2008 | A1 |
20080261834 | Simon | Oct 2008 | A1 |
20090038797 | Skala | Feb 2009 | A1 |
20090124522 | Roddy | May 2009 | A1 |
20090236097 | Roddy et al. | Sep 2009 | A1 |
20090260544 | Roddy et al. | Oct 2009 | A1 |
20100016183 | Roddy et al. | Jan 2010 | A1 |
20100025039 | Roddy et al. | Feb 2010 | A1 |
20100095871 | Patil et al. | Apr 2010 | A1 |
20100096135 | Roddy et al. | Apr 2010 | A1 |
20100252259 | Horton | Oct 2010 | A1 |
20110162845 | Ravi et al. | Jul 2011 | A1 |
20110237467 | Cornette | Sep 2011 | A1 |
20110312857 | Amanullah et al. | Dec 2011 | A1 |
20130312641 | Chatterji et al. | Nov 2013 | A1 |
Number | Date | Country |
---|---|---|
2514492 | Sep 2004 | CA |
2153372 | Jan 2006 | CA |
101544488 | Sep 2009 | CN |
102007042078 | Mar 2009 | DE |
102007059424 | Jun 2009 | DE |
0748782 | Dec 1996 | EP |
0814067 | Dec 1997 | EP |
1236701 | Sep 2002 | EP |
1394137 | Jul 2003 | EP |
1348831 | Oct 2003 | EP |
1686234 | Aug 2006 | EP |
1719741 | Nov 2006 | EP |
2465910 | Nov 2009 | EP |
2623579 | Aug 2013 | EP |
2787105 | Jun 2000 | FR |
1469954 | Apr 1997 | GB |
2429725 | Mar 2007 | GB |
52117316 | Oct 1977 | JP |
10110487 | Apr 1998 | JP |
1373781 | Feb 1988 | SU |
WO 8301443 | Apr 1983 | WO |
WO 9011977 | Apr 1990 | WO |
WO 9011977 | Oct 1990 | WO |
WO 9705079 | Feb 1997 | WO |
WO 9749644 | Dec 1997 | WO |
WO 9854108 | Dec 1998 | WO |
WO 0063134 | Jan 2000 | WO |
WO 0034199 | Jun 2000 | WO |
WO 0049272 | Aug 2000 | WO |
WO 0050357 | Aug 2000 | WO |
WO 0187796 | Nov 2001 | WO |
WO 03008756 | Jan 2003 | WO |
WO 03031364 | Apr 2003 | WO |
WO 2004001188 | Dec 2003 | WO |
WO 2004057715 | Jul 2004 | WO |
WO 2004101951 | Nov 2004 | WO |
WO 2004101952 | Nov 2004 | WO |
WO 2005047212 | May 2005 | WO |
WO 2005061846 | Jul 2005 | WO |
WO 2005080287 | Aug 2005 | WO |
WO 2006032841 | Mar 2006 | WO |
WO 2006053896 | May 2006 | WO |
WO 2008034461 | Mar 2008 | WO |
WO 2009030758 | Mar 2009 | WO |
2011049618 | Dec 2011 | WO |
2013191867 | Dec 2013 | WO |
Entry |
---|
Herndon, “Setting Downhole Plugs: A State-of-the-Art”, Petroleum Engineer International, Apr. 1978. |
“API Specification for Materials and Testing for Well Cements”, API Spec. 10, 5th ed., pp. 7, 19-21, Jul. 1, 1980. |
Sersale, “Portland-Zeolite-Cement for Minimizing Alkali-Aggregate Expansion”, 1987. |
Smith, “Cementing” Society of Professional Engineers, pp. 14, 38, 1987. |
Roy, Della M., New Strong Cement Materials: Chemically Bonded Ceramics, Downloaded from www.sciencemag.org on Jul. 29, 2008, pp. 651-658, XP-002490242, Feb. 6, 1987. |
API Specification 10: Materials and Testing for Well Cements, pp. 7, 19-30, 1990. |
Dillenbeck, Robert L. III, The Effect of Microsilica on the Thermal Stability of Lightweight Cement Systems, Society of Petroleum Engineers, pp. 116-1-116-5, XP-002490243, 1990. |
Smith, “Cementing” Society of Petroleum Engineers, p. 38, 1990. |
“Appendix A”, API RP 13B-2, 2d ed.; pp. 6-8, Dec. 1, 1991. |
Dalrymple et al., “A Selective Water Control Process”, SPE 24330, 1992. |
Harris et al., “Successful Remedial Operations Using Ultrafine Cement”, SPE 24294, 1992. |
Heathman et al., “Case Histories Regarding the Application of Microfine Cements”, Cementing Technical Paper SPE 23926, 1992. |
Sugama, “Carbonation of Hydrothermally Treated Phosphate-Bonded Calcium Aluminate Cements”, pp. 1-9 (undated but admitted as prior art), 1992. |
Marfil, “Zeolite Crystallization in Portland Cement Concrete Due to Alkali-Aggregate Reaction”, 1993. |
Amer. Assoc. of Hwy. and Transportation Officials, ASTM Designation C42-94, Std. Test for Obtaining and Testing Drilled cores & Sawed Beams of Concrete, pp. 24-27, 1994. |
“Nano-silica—an additive for high-strength concrete,” Wagner et al., Wissenschaftliche Zeitschrift—Hoschule fuer Architektur und Bauwesen Weimar—Universitaet, 40 (5/6/7), 183-87, abstract only, 1994. |
Atkins, “Zeolite P in Cements: Its Potential for Immobilizing Toxic and Radioactive Waste Species”, 1995. |
Halamickova, “Water Permeability and Chloride Ion Diffusion in Portland Cement Mortars: Relationship to Sand Content and Critical Pore Diameter”, Cement and Concrete Research, vol. 25, No. 4, pp. 790-802, 1995. |
Janotka, “The Properties of Mortar Using Blends With Portland Cement Clinker, Zeolite Tuff and Gypsum”, 1995. |
ASTM Designation C496-96, Standard Test Method for Splitting Tensile Strength of cylindrical Specimens, pp. 265-268, 1996. |
“Manufacture of supplementary cementitious materials from cement kiln dust”, Mishulovich et al., World Cement Research and Development, p. 116-120, Mar. 1996. |
Rogers, “Designing a Remedial Acid Treatment for Gulf of Mexico Deepwater Turbidite Sands Containing Zeolite Cement”, 1996. |
Sugama, “Hot Alkali Carbonation of Sodium Metaphosphate Modified Fly Ash/Calcium Aluminate Blend Hydrothermal Cements”, pp. 1661-1672, Sep. 11, 1996. |
Janotka, “Effect of Bentonite and Zeolite on Durability of Cement Suspension Under Sulfate Attack”, 1998. |
Naiqian, “Study on the Suppression Effect of Natural Zeolite on Expansion of Concrete Due to Alkali-Aggregate Reaction”, 1998. |
Chan, Comparative Study of the Initial Surface Absorption and Chloride Diffusion of High Performance Zeolite Silica Fume and PFA concretes, 1999. |
Ding, “Extreme Vertices Design of Concrete With Combined Mineral Admixtures”, 1999. |
Poon, “A Study of the Hydration of Natural Zeolite Blended Cement Pastes”, 1999. |
Rieker et al., Particle Size Distribution Inferred from Small0Angle X-ray Scattering and Transmission Electron Microscopy, Langmuir, pp. 638-641, 1999. |
Feng, “Zeolite Ceramiste Cellular Concrete”, 2000. |
Halliburton Zonal Isolation “Shear Bond Testing”, Specialized Testing 434.030, Global Laboratory Best Practices, vol. 4, Mar. 2000. |
Bartlet-Gouedard, “A Non-Conventional Way of Developing Cement Slurry for Geothermal Wells”, 2001. |
Material Safety Data Sheet by Nyacol Nano Technologies, Inc., “Nyacol Nyasil 5” dated Sep. 6, 2001 and “Nyacol Nyasil 20”, May 17, 2001. |
“Effect of nano-SiOx and silica fume on cement paste water demand,” Li et al., Shenyang Jianzhu gongcheng Xueyuan Xuebao, Ziran Kexueban, 18(4), 278-281, abstract only, 2002. |
Flores-Velez, Characterization & Properties of Portland Cement Composites Incorp. Zinc-Iron Oxide Nanoparti˜les˜Journoafl Materials Science, pp. 983-988, XP-002490244, 2002. |
“Hydration reaction between C3S and fly ash, silica fume, nano-SiO2, and microstructure of hydrated pastes,” Ba et al., Guisuanyan Xuebao, 30(6), 780-784, abstract only, 2002. |
Industrial Specialties, “Basic Know-How About silica”, 2002 Eka Chemicals found at http://colloidalsilica.comlhtmlfiles/7—1asp, 2002. |
Industrial Specialties, “The cementing Tool”, 2002 Eka Chemicals found at http:l/www.colloidalsilica.com/htmlfiles/1—3—3.asp, 2002. |
“Comparison on properties of high strength concrete with nano-SiO2 and silica fume added,” Ye et al., Jianzhu Cailiao Xuebao, 6(4), 381-385, abstract only, 2003. |
“Effect of secondary interface microstructure on pore structure and performance of cement-based materials,” Feng et al., Cailiao Yanjiu Xuebao, 17(5), 489-494, abstract only, 2003. |
Research on properties of Portland cement added with nano-SiO2, Wang et al., RILEM Proceedings (2003), PRO 32 (International Conference on Advances in Concrete and Structures, vol. 1), 154-161, abstract only, 2003. |
“Study on compound effect of silica fume and nano-SiOx for cementing composite materials,” Tang et al., Guisuanyan Xuebao, 3(5), 523-527, abstract only, 2003. |
Jerzy Chrusciel and Ludomir Slusarski, Synthesis of Nanosilica by the Sol-Gel Method and its Activity Toward Polymers, Materials Science, vol. 21, pp. 461-469, Nov. 4, 2003. |
“Accelerating effects of colloidal nano-silica for beneficial calcium-silicate-hydrate formation in cement,” Bjornstrom et al., Chemical Physics Letters, 392 (1-3), 242-248, abstract only, 2004. |
“Effect of the particle size on the micro and nanostructural features of calcium phosphate cement: a kinetic analysis”, Biomaterials 25, 3453-3462, 2004. |
“Experimental study on cement-based composites with nano-SiO2,” Feng et al., Cailiao Kexue Yu Gongcheng Zuebao Bianjibu, 22(2), 224-227, 2004. |
“Optimization of silica fume, fly ash and amorphous nano-silica in superplasticized high-performance concrete,” Collepardi et al., American Concrete Institute, SP 2004, SP-221 (Eight CANMET/ACI International Conference on Fly Ash, Silica Fume, Slag, and Natrural Pozzolans in Concrete, 495-505, abstract only, 2004. |
“Strong and bioactive composites containing nano-silica-fused whiskers for bone repair,” Xu et al., Biomaterials, 25(19), 4615-4626, abstract only, 2004. |
“Alkali-activated binders by use of industrial by-products”, Buchwald et al., Cement and concrete Research 35, p. 968-793, 2005. |
Answer 3 of 24 Chemical Abstracts on STN “Effect of cement kiln dust substitution on chemical and physical properties and compressive strength of Portland and slag cements”, Adb El-aleem et al. (abstract only), 2005. |
“Beneficial use of Solid Waste in Maine”, Apr. 14, 2005. |
Hashimoto et al., Particle size distribution analysis for nano-Si02 powder by ultra-small angle X-ray scattering (USAXS) using synchrotron radiation, ASS, pp. 227-230, 2005. |
“Kiln Dusts”, Apr. 14, 2005. |
“Nano-concrete: possibilities and challenges,” Balaguru et al., RILEM Proceedings (2005), PRO 45 (2nd Int'l Symposium on Nanotechnology in construction (NICOM2), 233-243, abstract only, 2005. |
“Preparation of multifunctional dry-power paints,” Yanmin Gao, Faming Zhuanli Shenqing gongkai Shuomingshu, 4 pages, abstract only, 2005. |
“Standards for the Management of Cement Kiln Dust Waste”, Apr. 14, 2005. |
“Use of Cement Kiln Dust for the Stabilization of Soils”, R. L. Parsons, et al., Apr. 14, 2005. |
“A comparative study on the pozzolanic activity between nano-SiO2 and silica fume,” Ye et al., Journal of Wuhan Univ of Technology, Mat'ls Science Edition, 21(3), 153-157, abstract only, 2006. |
“Investigations on the preparation and mechanical properties of the nano-alumina reinforced cement composite,” Li et al., Materials Letters, 0(3), 356-359, abstract only, 2006. |
Li et al., “Investigations on the preparation and mechanical properties of the nano-alumina reinforced cement composite”, Science Direct Materials Letters 60, pp. 356-359, 2006. |
“Research on Reinforcement of cement composites and relevant mechanism,” Yu et al., Qiangdoa Keji Daxue Xuebao, Ziran Kexueban, 27(2), 148-151, abstract only, 2006. |
Cembinder W, “Deepwater Cementing”, Eka Chemicals and Akzo Nobel, Jun. 2006. |
Dan Mueller and Ramy Eid, Characterizing Early-State Physical Properties, Mechanical Behavior of Cement Designs, Drilling Contractor, pp. 50-52, Jun. 2006. |
Konstantin Sobolev, NSF Workshop on Nanomodification of Cementitious Materials: Portland Cement Concrete and Asphalt Concrete, “Nanomodification of Cement”, Aug. 2006. |
Cardenas and Struble, Electrokinetic Nanoparticle Treatment of Hardened Cement Paste for Reduction of Permeability, Journal of Materials in Civil Eng. @ ASCE, pp. 554-560, Aug. 2006. |
OSHA and ANSI, Material Safety Data Sheet, Silicon Nanopowder, Oct. 2006. |
“Antagonistic Effect of superplasticizer and colloidal nanosilica in the hydration of Alite and Belite pastes,” Bjoernstrom et al., Journal of Materials Science, 42(11), 3901-3907, abstract only, 2007. |
“Application of nanometer silica in inorganic nonmetallic materials,” Deng et al., Taoci (Xiangyang China), (9), 8-12, abstract only, 2007. |
Campillo et al., “Improvement of initial mechanical strength by nanoalumina in belite cements”, Science Direct, Materials Letters 61, pp. 1889-1892, 2007. |
“Effect of Nano-SiO2 on heat of hydration of portland cement,” Xu et al., Nanjing Gongye Daxue Xuebao, Ziran Kexeuban, 29(4), 45-48, abstract only, 2007. |
Halim et al., “Preparation of an ultra fast binding cement from calcium silicate-based mixed oxide nanoparticles”, Nanotechnology 18, 2007. |
“Reaction mechanism analyses of cement based composite materials modified by nano-silica,” Xu et al., Kuangye Gongcheng (Changsha, China), 27(3), 99-102, abstract only, 2007. |
Konstantin Sobelev and Miguel Ferrada-Gutierrez, Nanotechnology of Concrete (printed from Internet), Feb. 20, 2007. |
Alfa Aesar A. Johnson Matthew Company, Search Result Pages for “Nano”, Apr. 25, 2007. |
Chang et al., “Material Properties of Portland Cement Paste with Nano-Montmorillonite,” J. Material Science, May 18, 2007. |
Answer 13 of 24 Chemical Abstracts on STN “Manufacture of ceramic particles from floatstone and fly ash”, CN 1182062 (abstract only) (undated but admitted as prior art), 2008. |
Darbe, “Slurry Design Considerations for Mechanically Enhanced Cement Systems”, AADE-08-DF-HO-06, 2008. |
Epik Energy brochure entitled “Nanocement”, 2008. |
He et al., “Chloride Permeability and Microstructure of Portland Cement Mortars Incorporating Nanomaterials”, Abstract, Transportation Research Board Annual Meeting 2007 Paper #08-1041, 2008. |
Hunter, “Three Key Mechanisms Deliver Zonal Isolation”, IADC, 2008. |
Nanofil SE 3000, “Active nanofiller for polymr applications”, Product Bulletin/Nanofil, Southern Clay Products, 2008. |
Ravi, “Interventionless Zonal Isolation”, Cementing, May 2008. |
Montmorillonite, Wikipedia encyclopedia, 2009. |
Physical Properties of Klkem Microsilica, at http://www.refractories.elkem.com (printed from Internet), Mar. 5, 2009. |
Wikipedia, Nanoparticle, at http://en.wikipedia.org/wiki/Nanoparticle (Printed from Internet), Mar. 9, 2009. |
Andrew R. Barron, Chemical composition of Portland Cement, viewed on Aug. 26, 2013, last edited by author on Jan. 4, 2010. |
HES Brochure “SCR-100 Cement Retarder a Valuable Time Saver”, 1994. |
HES Brochure “SSA-1 Strenght-Stabilizing Agent”, 1998. |
HES Brochure “Pozmix Cement and Pozmix 140”, 1999. |
HES Brochure “ThermaLock™ Cement for Corrosive CO2 Environments”, Apr. 2006. |
HES Brochure “GasCon 469, Cement Additive”, May 2006. |
HES Brochure “Silicalite”, Jul. 2006. |
HES Brochure “Halad-344 Fluid Loss Additive”, Aug. 2007. |
HES Brochure HR-5 Cement Additive, Aug. 2007. |
HES Brochure “GasStop HT”, Aug. 2007. |
HES Brochure “Halad-413 Fluid Loss Additive”, Aug. 2007. |
HES Brochure “Howco Suds Surfactant”, Aug. 2007. |
HES Brochure “HR-7 Cement Retarder”, Aug. 2007. |
HES Brochure “HR-12 Cement Retarder”, Aug. 2007. |
HES Brochure “HR-15 Cement Retarder”, Aug. 2007. |
HES Brochure “HR-25 Cement Retarder”, Aug. 2007. |
HES Brochure “Pozmix a Cement Additive”, Aug. 2007. |
HES Brochure “Halad-23 Fluid Loss Additive”, Aug. 2007. |
HES Brochure “SCR-500L High Temp Retarder”, Aug. 2007. |
HES Brochure “Latex 2000”, Aug. 2007. |
HES Brochure “Micro Matrix Cement”, Aug. 2007. |
HES Brochure “SSA-2, Coarse Silica Four”, Feb. 2007. |
HES Brochure “MICROSAND Cement Additive, H01460”, Apr. 2007. |
HES Brochure “AQF-2 Foaming Agent”, Jan. 2008. |
HES Brochure, “WellLife III Cementing Service for CO2 Environments”, Jun. 2009. |
HES Brochure “HR-4 Cement Retarder”, Aug. 2010. |
HES Brochure “SCR-100 Cement Retarder”, Nov. 2010. |
HES Brochure, “WellLife III Cementing Service”, Jan. 2012. |
“3M Scotchlite, Glass Bubbles Floated Product Series Product Information”, 2002. |
Lafarge brochure “TerraCem™”, Aug. 2006. |
Lafarge MSDS “Cement Kiln Dust”, Mar. 3, 2005. |
Lafarge MSDS “LaFarge Blended Cement (cement)”, Mar. 3, 2005. |
Nanocor brochure entitled “Nanoclay Structure”, Jun. 24, 2008. |
Nanocor Technical brochure entitled “Nanoclay Structures”, May 5, 2006. |
Schlumberger brochure, “Future Active set-cement technology for long-term zonal isolation”, 2007. |
TXI Material Safety Data Sheet for PRESSUR-SEAL, Oct. 2003. |
Nyacol Nano Technologies, Inc., Silica Additives, Sep. 1998. |
Nyacol Nano Technologies, Inc., NexSil Silicon Wafer Polishing Slurries NexSil 3500, 6000, 5000 and 5000 HP, May 2005. |
Nyacol Nano Technologies, Inc., NexSil Aqueous Colloidal Silica, Nov. 2005. |
Office Action from U.S. Appl. No. 10/775,348, Nov. 23, 2005. |
Office Action from U.S. Appl. No. 11/223,671, Dec. 15, 2005. |
Office Action from U.S. Appl. No. 11/271,431, Mar. 6, 2006. |
Final Office Action from U.S. Appl. No. 11/223,671, Mar. 31, 2006. |
Final Office Action from U.S. Appl. No. 10/775,348, May 2, 2006. |
Final Office Action from U.S. Appl. No. 11/271,431, May 17, 2006. |
Notice of Allowance from U.S. Appl. No. 10/775,348, Jun. 6, 2006. |
Office Action from U.S. Appl. No. 11/271,431 (Advisory Action), Jul. 11, 2006. |
Office Action from U.S. Appl. No. 11/416,563, Jul. 21, 2006. |
Office Action from U.S. Appl. No. 11/403,032, Jul. 24, 2006. |
Office Action from U.S. Appl. No. 11/271,431, Aug. 15, 2006. |
Office Action from U.S. Appl. No. 11/440,627, Aug. 21, 2006. |
Office Action from U.S. Appl. No. 11/402,741, Oct. 19, 2006. |
Office Action from U.S. Appl. No. 11/484,951, Oct. 26, 2006. |
Notice of Allowance from U.S. Appl. No. 11/271,431, Nov. 2, 2006. |
Office Action from U.S. Appl. No. 11/484,951, Dec. 21, 2006. |
Office Action from U.S. Appl. No. 11/223,703, Jan. 17, 2007. |
Final Office Action from U.S. Appl. No. 11/402,741, Feb. 2, 2007. |
Office Action from U.S. Appl. No. 11/223,485, Feb. 28, 2007. |
Office Action from U.S. Appl. No. 11/223,669, Feb. 28, 2007. |
Notice of Allowance from U.S. Appl. No. 11/484,951, Mar. 12, 2007. |
Office Action from U.S. Appl. No. 11/271,690, Mar. 13, 2007. |
Office Action from U.S. Appl. No. 11/402,741, Mar. 22, 2007. |
Final Office Action from U.S. Appl. No. 11/223,703, Apr. 25, 2007. |
Final Office Action from U.S. Appl. No. 11/402,741, May 29, 2007. |
Final Office Action from U.S. Appl. No. 11/223,669, Jun. 18, 2007. |
Notice of Allowance from U.S. Appl. No. 11/416,754, Jul. 2, 2007. |
Notice of Allowance from U.S. Appl. No. 11/223,485, Aug. 3, 2007. |
Office Action from U.S. Appl. No. 11/257,261, Aug. 10, 2007. |
Notice of Allowance from U.S. Appl. No. 11/271,690, Aug. 13, 2007. |
Office Action from U.S. Appl. No. 11/402,741, Sep. 6, 2007. |
Office Action from U.S. Appl. No. 11/223,669, Oct. 9, 2007. |
Office Action from U.S. Appl. No. 11/223,750, Oct. 16, 2007. |
Notice of Allowance from U.S. Appl. No. 11/416,754, Oct. 17, 2007. |
Notice of Allowance from U.S. Appl. No. 11/257,261, Oct. 23, 2007. |
Final Office Action from U.S. Appl. No. 11/402,741, Oct. 24, 2007. |
Notice of Allowance from U.S. Appl. No. 11/223,750, Dec. 11, 2007. |
Notice of Allowance from U.S. Appl. No. 11/402,741, Dec. 13, 2007. |
Notice of Allowance from U.S. Appl. No. 11/388,644, Jan. 3, 2008. |
Office Action from U.S. Appl. No. 11/223,669, Jan. 29, 2008. |
Notice of Allowance from U.S. Appl. No. 11/256,824, Feb. 27, 2008. |
Notice of Allowance from U.S. Appl. No. 11/223,703, Feb. 27, 2008. |
Office Action from U.S. Appl. No. 11/747,002, Apr. 2, 2008. |
Final Office Action from U.S. Appl. No. 11/223,669, Apr. 8, 2008. |
Office Action from U.S. Appl. No. 12/008,923, May 20, 2008. |
Office Action from U.S. Appl. No. 11/747,002, May 27, 2008. |
Notice of Allowance from U.S. Appl. No. 11/223,669, Jun. 30, 2008. |
Office Action from U.S. Appl. No. 11/747,002, Jul. 10, 2008. |
Notice of Allowance from U.S. Appl. No. 12/008,923, Jul. 22, 2008. |
Notice of Allowance from U.S. Appl. No. 11/747,002, Oct. 21, 2008. |
Notice of Allowance from U.S. Appl. No. 12/034,886, Oct. 21, 2008. |
Office Action from U.S. Appl. No. 11/747,002, Dec. 22, 2008. |
Office Action from U.S. Appl. No. 11/747,002, Mar. 3, 2009. |
Office Action from U.S. Appl. No. 11/388,645, Apr. 3, 2009. |
Final Office Action from U.S. Appl. No. 11/388,645, Jul. 30, 2009. |
Office Action from U.S. Appl. No. 11/388,645, Dec. 10, 2009. |
Office Action from U.S. Appl. No. 12/426,645, May, 5, 2010. |
Office Action from U.S. Appl. No. 12/472,561, May, 5, 2010. |
Notice of Allowance from U.S. Appl. No. 12/426,645, Jun. 23, 2010. |
Notice of Allowance from U.S. Appl. No. 12/472,561, Jun. 29, 2010. |
Office Action from U.S. Appl. No. 12/426,393, Jul. 2, 2010. |
Final Office Action from U.S. Appl. No. 11/388,645, Aug. 17, 2010. |
Office Action from U.S. Appl. No. 12/833,189, Oct. 1, 2010. |
Office Action from U.S. Appl. No. 12/833,189, Nov. 10, 2010. |
Notice of Allowance from U.S. Appl. No. 12/426,393, Dec. 16, 2010. |
Office Action from U.S. Appl. No. 12/833,189, Feb. 17, 2011. |
Office Action from U.S. Appl. No. 12/567,782, Apr. 5, 2011. |
Office Action from U.S. Appl. No. 12/651,662, Apr. 5, 2011. |
Office Action from U.S. Appl. No. 12/567,783, Apr. 6, 2011. |
Office Action from U.S. Appl. No. 12/263,954, Apr. 20, 2011. |
Final Office Action from U.S. Appl. No. 12/833,189, May 16, 2011. |
Office Action from U.S. Appl. No. 12/833,189, Jul. 18, 2011. |
Office Action from U.S. Appl. No. 12/263,954, Aug. 8, 2011. |
Final Office Action from U.S. Appl. No. 12/567,783, Aug. 23, 2011. |
Office Action from U.S. Appl. No. 12/651,662, Sep. 15, 2011. |
Final Office Action from U.S. Appl. No. 12/833,189, Oct. 11, 2011. |
Office Action from U.S. Appl. No. 12/651,662, Nov. 28, 2011. |
Office Action from U.S. Appl. No. 12/833,189, Feb. 7, 2012. |
Office Action from U.S. Appl. No. 12/567,782, Mar. 2, 2012. |
Office Action from U.S. Appl. No. 13/052,471, Mar. 6, 2012. |
Office Action from U.S. Appl. No. 12/651,662, Mar. 14, 2012. |
Final Office Action from U.S. Appl. No. 13/052,471, Jun. 28, 2012. |
Office Action from U.S. Appl. No. 12/567,782, Jul. 25, 2012. |
Office Action from U.S. Appl. No. 12/651,662, Aug. 2, 2012. |
Office Action from U.S. Appl. No. 13/431,701, Nov. 9, 2012. |
Office Action from U.S. Appl. No. 13/052,471, Feb. 4, 2013. |
Office Action from U.S. Appl. No. 12/833,189, Feb. 6, 2013. |
Final Office Action from U.S. Appl. No. 12/567,782, Feb. 8, 2013. |
Final Office Action from U.S. Appl. No. 12/651,662, Feb. 13, 2013. |
Final Office Action from U.S. Appl. No. 13/443,934, Mar. 4, 2013. |
Final Office Action from U.S. Appl. No. 12/263,954, Mar. 14, 2013. |
Final Office Action from U.S. Appl. No. 13/435,701, Mar. 14, 2013. |
Final Office Action from U.S. Appl. No. 13/458,112, Mar. 15, 2013. |
Notice of Allowance from U.S. Appl. No. 12/651,662, May 10, 2013. |
Final Office Action from U.S. Appl. No. 13/052,471, May 10, 2013. |
Final Office Action from U.S. Appl. No. 12/833,189, May 28, 2013. |
Office Action from U.S. Appl. No. 12/567,782, Jun. 21, 2013. |
Office Action from U.S. Appl. No. 13/443,934, Jun. 27, 2013. |
Office Action from U.S. Appl. No. 13/435,701, Jul. 11, 2013. |
Office Action from U.S. Appl. No. 13/458,112, Sep. 15, 2013. |
Office Action from U.S. Appl. No. 12/263,954, Oct. 8, 2013. |
Notice of Allowance from U.S. Appl. No. 12/567,782, Oct. 8, 2013. |
Notice of Allowance from U.S. Appl. No. 12/833,189, Oct. 15, 2013. |
PCT International Search Report and Written opinion for PCT/GB2008/001524, Nov. 10, 2009. |
PCT International Searching Authority for International Application No. PCT/GB2009/002596, Jul. 23, 2010. |
PCT International Search Report for International Application No. PCT/GB2010/001805, Mar. 31, 2011. |
PCT International Search Report for International Application No. PCT/GB2010/001806, Mar. 31, 2011. |
PCT International Search Report and Written Opinion for International Application No. PCT/GB2011/000003, Jul. 7, 2011. |
PCT International Preliminary Report on Patentability and Written Opinionfor International Application No. PCT/GB2009/002596, May 3, 2011. |
PCT International Search Report and Written Opinion for International Application No. PCT/GB2010/000485, Oct. 25, 2011. |
PCT International Search Report and Written Opinion for International Application No. PCT/GB2010/001045, Nov. 29, 2011. |
Communication from EPO for EPO Application No. 12159772.8, Mar. 5, 2012. |
PCT International Preliminary Report and Written Opinion for International Application No. PCT/GB2010/001805, Mar. 27, 2012. |
PCT International Preliminary Report and Written Opinion for International Application No. PCT/GB2010/001806, Mar. 27, 2012. |
PCT International Written Opinion for International Application No. PCT/GB/2011/000003, Jul. 4, 2012. |
PCT Search Report and Written Opinion for International Application No. PCT/US2013/038343, Jul. 31, 2013. |
USPTO Office Action for U.S. Appl. No. 12/567,783 dated Oct. 3, 2013. |
USPTO Office Action for U.S. Appl. No. 13/435,701 dated Oct. 4, 2013. |
EPO Office Action for Application Serial No. 09751959.9 dated Sep. 27, 2013. |
USPTO Office Action for U.S. Appl. No. 13/458,112 dated Dec. 26, 2013. |
USPTO Notice of Allowance for U.S. Appl. No. 13/052,471 dated Jan. 30, 2014. |
HES Brochure “FlexPlug Services” dated Apr. 2008. |
HES Brochure “Thermatek Services” dated May 2005. |
HES Brochure “Fuse-It Circulation Treatment” dated May 2006. |
USPTO Office Action for U.S. Appl. No. 14/145,402 dated Jun. 19, 2014. |
USPTO Office Action for U.S. Appl. No. 14/145,402 dated Oct. 23, 2014. |
EPC Official Action for Application EP14184678 dated Jan. 28, 2015. |
USPTO Official Action for U.S. Appl. No. 14/145,402 dated Feb. 6, 2015. |
USPTO Final Office Action for U.S. Appl. No. 14/145,402 dated Mar. 3, 2016. |
USPTO Office Action for U.S. Appl. No. 14/145,402 dated Jun. 30, 2016. |
Number | Date | Country | |
---|---|---|---|
20140008067 A1 | Jan 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12472561 | May 2009 | US |
Child | 12833189 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12833189 | Jul 2010 | US |
Child | 14025638 | US | |
Parent | 12426645 | Apr 2009 | US |
Child | 12472561 | US | |
Parent | 11747002 | May 2007 | US |
Child | 12426645 | US |